FOMAT

Oncology

FOMAT Prime Therapeutic Areas provide highly specialized research sites with strong infrastructure, expert investigators, and proven recruitment models. In Oncology, we support studies across breast cancer, lung cancer, colorectal cancer, prostate cancer, and other solid tumors with specialized Phase 1 infrastructure, advanced imaging access, infusion capabilities, and research ready operations designed for complex oncology protocols.
Patient records accessible through FOMAT’s oncology research network
0
Phase 1 unit beds with 24 hour PKs capabilities and overnight stay
0
Oncology infusion suites supporting protocol driven administration workflows
0 /7
Oncology specialists across key subspecialties supporting trial coverage
0

Oncology clinical trial capabilities

Our oncology clinical trial capabilities include advanced imaging and diagnostics access, experienced research teams, and tailored operational support across phases. We ensure consistent trial delivery with specialized infrastructure and reliable execution for complex oncology protocols.
  • Oncology specific imaging access including PET/CT scanners, MRI, bone scan, ECHO or Muga, and ultrasound
  • Phase 1 unit infrastructure including 11 beds, patient examination and treatment planning rooms, and patient waiting areas
  • Oncology specific capabilities including chemo prep and administration, tumor and tissue cryopreservation, radiotherapy and radioisotope capabilities, and 24/7 oncology infusion suites
  • Research infrastructure and storage including temperature controlled storage with continuous monitoring, backup generator and alarm system, plus -20°C and -80°C freezers
  • Integrated electronic systems including EHR, CTMS, eCRFs or eSource, eReg, and eConsent
  • Oncology team coverage across key subspecialties, including medical oncology, nuclear medicine, radiation oncology, gynecologic oncology, and surgical oncology
Oncology | FOMAT

Key differentiators

Reliable start-up execution
Dedicated specialists across regulatory, finance, QC and QA, and start up support streamlined activation and predictable execution.
Experienced Oncology Investigators
Experienced oncology leadership with expertise spanning Phase I to IV oncology trials, protocol development, regulatory compliance, and medical affairs, supported by a multidisciplinary team across oncology subspecialties.
Real-time data management
Integrated platforms (EHR, CTMS, eSource or eCRFs, eReg, eConsent) support organized workflows and sponsor ready documentation. 
Comprehensive recruitment & retention
Large access to patients through direct community reach and EMR based identification, supported by active clinical trial sites and referral locations and demonstrated enrollment and retention performance. 
Infrastructure for all study phases
Specialized oncology infrastructure supports early to late phase execution, including Phase 1 beds, imaging access, infusion and chemo administration capabilities, and cryopreservation and radiotherapy readiness.